| Symbol | KHRNF |
|---|---|
| Name | KHIRON LIFE SCIENCES CORP. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | M5X 1G5 Canada ON 100 King Street West Suite 1600 |
| Telephone | +1 (647) 556-5750 |
| Fax | — |
| — | |
| Website | https://www.khiron.ca |
| Incorporation | CA |
| Incorporated On | 2012 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | BDO Canada LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Foreign Issuer - Not Listed on Foreign Exchange |
| CIK | 0001873100 |
| Description | Khiron is a leading global medical cannabis company with core operations in Latin America and Europe. Leveraging wholly-owned medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and focus on creating access to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Germany, the United Kingdom, Peru, and Brazil and is positioned to commence sales in Mexico. The Company is led by its co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and board of directors. Additional info from OTC: |
No news found.